$Amgen (AMGN.US)$ 🚨 FDA approves Blincyto® for a specific t...

$Amgen(AMGN.US)$ 🚨
FDA approves Blincyto® for a specific type of leukemia* in consolidation phase

*CD19-Positive Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (B-All)

» Blincyto® + chemo cuts death risk by 58% in consolidation phase 👏
» superior survival vs. chemo alone
» 1st BiTE® therapy for consolidation, regardless of MRD status
» marks the 3rd indication for BLINCYTO